Health
Vaccine experts meeting over clot report – The Young Witness
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……

A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
Noosa News9 hours ago
How Lily Steele-Park took her rapist to court and won
-
General23 hours ago
‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General24 hours ago
Strictly embargoed! The gaming of the press release